<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="4721" end="4727" sStart="4617" offset="104" sid="r11.strong.j.0949" wn="1" wnkey="strong%3:00:00::" text="This activation of the p110-PI 3-kinase/PKB pathway, and inhibition of GSK3, delivers a strong anti-apoptotic signal to the cell [ 23, 24, 25]." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-12.anc" start="20191" end="20195" sStart="null" offset="0" sid="null" wn="1" wnkey="part%1:24:00::" text="GSK3?-dependent phosphorylation of p53 at serine 33 may be &lt;b&gt;part&lt;/b&gt; of other p53-regulatory pathways, such as oncogene activation or apoptosis, which are not directly activated by DNA-damage." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-2-12.anc" start="20191" end="20195" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="GSK3?-dependent phosphorylation of p53 at serine 33 may be &lt;b&gt;part&lt;/b&gt; of other p53-regulatory pathways, such as oncogene activation or apoptosis, which are not directly activated by DNA-damage." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="10783" end="10789" sStart="null" offset="73" sid="r9.level.n.0748" wn="2" wnkey="level%1:26:01::" text="Both the S33A and S37A mutations displayed slightly higher basal levels of transcriptional activity than the wtp53 protein." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="4103" end="4111" sStart="null" offset="186" sid="r11.function.n.0223" wn="7" wnkey="function%1:10:00::" text="In this study, we have examined how Glycogen Synthase Kinase 3? (GSK3?), a protein kinase involved in tumorigenesis, differentiation and apoptosis, regulates the function of p53 [ 23, 24]." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="14982" end="14990" sStart="null" offset="95" sid="r11.function.n.0483" wn="2" wnkey="function%1:07:00::" text="However, disruption of GSK3? in mice results in embryonic lethality and impaired NF? B function [ 37], indicating that GSK3? cannot substitute for GSK3? in this model system." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="11399" end="11406" sStart="null" offset="199" sid="r11.absence.n.0785" wn="1" wnkey="absence%1:26:00::" text="The ability of GSK3? to activate each construct was calculated by expressing the p53 transcriptional activity in the presence of GSK3? as a percentage of that observed in the absence of GSK3?." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-2-12.anc" start="8858" end="8865" sStart="null" offset="7" sid="r11.absence.n.0537" wn="1" wnkey="absence%1:26:00::" text="In the absence of p53, no phosphorylation by GSK3? was detected (fig 2)." />
  </sentences>
</list>